TAO SHEN to Prognosis
This is a "connection" page, showing publications TAO SHEN has written about Prognosis.
Connection Strength
0.370
-
Development and functional validation of a disulfidoptosis-related gene prognostic model for lung adenocarcinoma based on bioinformatics and experimental validation. Front Immunol. 2025; 16:1540578.
Score: 0.115
-
Integrative machine learning frameworks to uncover specific protein signature in neuroendocrine cervical carcinoma. BMC Cancer. 2025 Jan 10; 25(1):57.
Score: 0.115
-
CircMETTL6 Suppresses Ovarian Cancer Cell Growth and Metastasis Through Inhibition of GDF15 Transcription by Disrupting the NONO-POLR2A Complex. Adv Sci (Weinh). 2025 Mar; 12(12):e2411717.
Score: 0.029
-
Multi-omics identification of a signature based on malignant cell-associated ligand-receptor genes for lung adenocarcinoma. BMC Cancer. 2024 Sep 12; 24(1):1138.
Score: 0.028
-
Genome-wide analyses reveal the regulatory roles of DNA methylation-regulated alternative promoter transcripts in breast cancer. Hum Genet. 2024 Mar; 143(3):385-399.
Score: 0.027
-
Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2. Front Immunol. 2023; 14:1155182.
Score: 0.026
-
CSH guidelines for the diagnosis and treatment of drug-induced liver injury. Hepatol Int. 2017 May; 11(3):221-241.
Score: 0.017
-
CXCL8, overexpressed in colorectal cancer, enhances the resistance of colorectal cancer cells to anoikis. Cancer Lett. 2015 May 28; 361(1):22-32.
Score: 0.014